Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05768217 · ClinicalTrials.gov registry record · NA
Community Resiliency Collective Efficacy Intervention
A NA study of Violence in Adolescence and Violence, Domestic, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 4,600
- Enrollment target
- 1
- Study location
NCT05768217: Recruiting NA study of Violence in Adolescence and Violence, Domestic, sponsored by University of Pittsburgh.
NCT05768217 is a NA study of Violence in Adolescence and Violence, Domestic that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 4,600 participants, above the 272-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (1591% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05768217, a NA study of Violence in Adolescence and Violence, Domestic, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,600 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.
Primary Outcome
Composite Measure mean score (range 1 - 5; 1 is low and 5 is best) of neighborhood-level perceptions of collective efficacy and community cohesion
Conditions Studied
Interventions
- BEHAVIORAL Community Resiliency Collective Efficacy Intervention (CRCEI)
- BEHAVIORAL Health Education Sessions
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,600 participants |
| Start Date | 2024-06-24 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT05768217 shows while recruiting
NCT05768217 is an interventional study that assigns participants to a tested intervention. Its 4,600 participants enrollment target places it among the larger protocols in the corpus, above the 272-participant average among 9 other Violence in Adolescence trials with a reported enrollment target (1591% higher).
The record links to 8 conditions, with Violence in Adolescence appearing as the primary indexed condition, and to 2 interventions - of which Community Resiliency Collective Efficacy Intervention (CRCEI) is the first listed.
NCT05768217 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05768217 about?
NCT05768217 is a clinical study titled "Community Resiliency Collective Efficacy Intervention". This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.
What is the current status of trial NCT05768217?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,600 participants. The study started on 2024-06-24. Estimated completion is 2027-09-30.
What conditions does trial NCT05768217 study?
This clinical trial studies the following conditions: Violence in Adolescence, Violence, Domestic, Violence, Physical, Violence, Sexual, Violence, Non-accidental.
What interventions are being tested in trial NCT05768217?
The interventions under investigation include: Community Resiliency Collective Efficacy Intervention (CRCEI) (BEHAVIORAL), Health Education Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05768217?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05768217 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Violence in Adolescence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05768217's enrollment target sits among peer trials
4,600 1st of 9 higher than 9 of 9 other Violence in Adolescence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Violence in Adolescence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy
RECRUITING · NA
-
The Healthy Families Bright Futures Program
RECRUITING · NA
-
Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation
RECRUITING · NA
-
Forging Hopeful Futures to Reduce Youth Violence
ACTIVE NOT RECRUITING · NA
-
Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement
ACTIVE NOT RECRUITING · NA
-
BrotherlyACT: A Tech-Enhanced Violence and Substance Use Intervention for Black Boys and Young Men
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT06702878 · 4,514 participants · Phase 3
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
- NCT05486572 · 4,700 participants · NA
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI